Reporting Owner Activity for Pravin Dugel

Form 3/4/5 issuer positions and transaction evidence for this reporting owner.

Issuer positions

3

Largest position

OCULAR THERAPEUTIX, INC

Disclosed value

$27.21M

Recent activity

Available

Identity
Location
Cincinnati, OH
SEC ownership signals
Ownership summary

Disclosed holdings value

$27,207,742

Estimated from parsed Forms 3/4/5 holdings when values are available.

Issuer positions

3

Distinct issuers linked to this reporting owner in parsed SEC filings.

Largest parsed position

OCULAR THERAPEUTIX, INC (OCUL)

About $27.18M reported in parsed filings.

Latest ownership filing

28 May 2026

Most recent owner-level filing date in the parsed SEC record.

+1 more

Additional issuer positions are listed below.

Values come from parsed SEC Forms 3/4/5 and should be verified against the source filing.

SEC record
Reporting signature
/s/ Todd Anderman, Attorney-in-Fact for Pravin Dugel
SEC evidence
Source filings
Open source filing history

Follow Filing Activity

Follow Pravin Dugel and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Reported issuer positions for Pravin Dugel

Insider Transactions Reported by Pravin Dugel:

Sym Company Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .